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Abstract Reactive gliosis, in which astrocytes as well as
other types of glial cells undergo massive proliferation, is a
common hallmark of all brain pathologies. Brain-type fatty
acid-binding protein (FABP7) is abundantly expressed in
neural stem cells and astrocytes of developing brain, sug-
gesting its role in differentiation and/or proliferation of
glial cells through regulation of lipid metabolism and/or
signaling. However, the role of FABP7 in proliferation of
glial cells during reactive gliosis is unknown. In this study,
we examined the expression of FABP7 in mouse cortical
stab injury model and also the phenotype of FABP7-KO
mice in glial cell proliferation. Western blotting showed
that FABP7 expression was increased signiﬁcantly in the
injured cortex compared with the contralateral side. By
immunohistochemistry, FABP7 was localized to GFAP
?
astrocytes (21% of FABP7
? cells) and NG2
? oligoden-
drocyte progenitor cells (62%) in the normal cortex. In the
injured cortex there was no change in the population of
FABP7
?/NG2
? cells, while there was a signiﬁcant increase
in FABP7
?/GFAP
? cells. In the stab-injured cortex of
FABP7-KO mice there was decrease in the total number of
reactive astrocytes and in the number of BrdU
? astrocytes
compared with wild-type mice. Primary cultured astrocytes
from FABP7-KO mice also showed a signiﬁcant decrease
in proliferation and omega-3 fatty acid incorporation
compared with wild-type astrocytes. Overall, these data
suggest that FABP7 is involved in the proliferation of
astrocytes by controlling cellular fatty acid homeostasis.
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progenitor cell   Reactive gliosis   Brain injury
Introduction
Polyunsaturated fatty acids (PUFAs) have important met-
abolic, structural and signal transducing roles. PUFAs are
abundant in the developing brain and are essential for
normal development of the brain. Several studies have
suggested a negative correlation between dietary con-
sumption of PUFAs and risk of several neuropsychiatric
diseases such as multiple sclerosis (Esparza et al. 1995;
Lauer 1994; Swank et al. 1952), Parkinson disease (de Lau
et al. 2005), Alzheimer disease (Barberger-Gateau et al.
2002; Morris et al. 2003), schizophrenia (Fedorova et al.
2009; Amminger et al. 2010), depression, other psychotic
and mood disorders and developmental disorders like
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DOI 10.1007/s00418-011-0865-4ADHD and autism (Muskiet and Kemperman 2006;
Hedelin et al. 2010). Therapeutic effects of PUFAs have
also been suggested even in these diseases, and PUFA
supplements are currently recommended to these patients
as alternative or complementary medicine (Peet et al. 2001;
Nordvik et al. 2000; Weinstock-Guttman et al. 2005).
Nevertheless, there is limited evidence to support pre-
ventive and therapeutic effects of PUFAs (Ross et al. 2007;
Mehta et al. 2009).
Fatty acid-binding proteins (FABPs) are intracellular
low-molecular-weight (14–15 kDa) polypeptides and are
key molecules in the uptake, transportation and storage of
long-chain fatty acids and in mediating their signal trans-
duction and gene regulation activities. Twelve members of
the FABP family have been recognized so far, which are
differentially expressed in different organs, tissues and cell
types. FABP7 (brain-type FABP), a strong binder of
omega-3 PUFAs, is abundantly expressed in neural stem
cells and astrocytes of the developing brain, suggesting a
role in glial cell differentiation and proliferation of glial
cells (Owada et al. 1996; Maekawa et al. 2011). However,
the functional signiﬁcance of FABP7 expression in cortical
astrocytes under normal and pathological conditions
remains unknown.
Reactive gliosis, whereby astrocytes and other types of
glial cells undergo massive proliferation, is a common
hallmark of numerous brain pathologies. However, the
underlying mechanisms of gliosis are largely unknown.
Reactive gliosis consists of a range of molecular and
morphological changes, especially in astrocytes, including
cellular hypertrophy, alteration in molecular expression,
proliferation and scar formation. Recently, it was reported
that docosahexaenoic acid (DHA), a ligand of FABP7,
prevents degradation of neurons and astrocytes following
brain ischemia and spinal cord injury by protection of
neurons and astrocytes from cell degeneration (Belayev
et al. 2011), suggesting a role for FABP7 in regulating
CNS injury. Furthermore, there is an association of FABP7
with poor prognosis of malignant glioma (Godbout et al.
1998; Tso et al. 2006; Liang et al. 2005; Kaloshi et al.
2007), providing support for a role of FABP7 in astrocytes
responses to injury. FABP7 is also abundantly expressed in
neural stem cells and plays a role in maintenance of neu-
roepithelial cells during early developmental stages (Arai
et al. 2005), and as such, may be important in adult neural
cell progenitors, which share some characteristics of neural
stem cells .
In the present study, we examined the detailed locali-
zation of FABP7 in the normal and stab-injured brain
cortex of adult mice and determined its role in astrocyte
proliferation in vivo and in vitro using FABP7 knockout
(KO) mice (Owada et al. 2006). We found that FABP7
regulated the proliferative response of astrocytes to injury.
Furthermore, we observed novel expression of FABP7 in
oligodendrocyte progenitor cells (OPCs).
Materials and methods
Animals
Three-month-old male C57BL/6 mice (14 wild-type and 14
FABP7-KO) (Owada et al. 2006) were used for brain
cortex stab injury experiments. All experimental protocols
were reviewed by the Ethics Committee for Animal
Experimentation of Yamaguchi University School of
Medicine and were performed according to the Guidelines
for Animal Experimentation of the Yamaguchi University
School of Medicine and Under Law and Notiﬁcation
requirements of the Japanese Government.
Stab injury model
Animals were anesthetized (Isoﬂurane; Abbott, IL, USA)
using a small animal anesthetizer (Muromachi Co., Tokyo,
Japan) and a 1-mm-deep stab wound was made on the right
cerebral neocortex (Bregma, -1t o-2.5 mm. Latero-lat-
eral, 1.5–2.5 mm) (Buffo et al. 2005) (see Supplementary
Fig. 1a, e). Mice were killed at 3 (n = 7 for wild-type
mice, n = 7 for FABP7-KO mice) and 7 (n = 7) days post
lesion (DPL).
Cell culture
For primary cultured astrocytes, the cerebral cortices of
newborn mice (wild-type and FABP7-KO) were dissected,
and the meninges were carefully removed. Tissues were cut
into small pieces in HBSS (Hanks buffer salt solution)
supplemented with glucose, penicillin and streptomycin
and further dissociated by trypsin treatment (0.25%) at
37C for 20 min. Debris was removed by ﬁltering through
a 100-lm mesh, and the cell suspension was centrifuged at
1,000 rpm and 20C for 5 min. The supernatant was
removed and the pellet was resuspended in DMEM sup-
plemented with 10% FBS, penicillin, streptomycin and
amphotericin B and then seeded at a density of 2 9 10
6
cells per T25 ﬂask. Cells were incubated in a 5% CO2
incubator at 37C until cells became conﬂuent. The culture
ﬂasks were shaken on an orbital shaker (BR-40LF; TAI-
TEC, Koshigaya, Japan) at 200 rpm and 37C for more
than 14 h to detach loosely attached microglia and OPCs
from the astrocytic bed. Immediately after shaking, the
cells were washed three times with PBS and culture med-
ium was refreshed. After 2-day incubation in 5% CO2 at
37C, ﬂasks were washed with PBS for three times and
treated with trypsin/EDTA/PBS for 5 min at 37C. The
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123purity of astrocytes was conﬁrmed to be[95% by GFAP
immunostaining.
OPC culture was performed as described before
(Nishiyama et al. 2010). OPCs in mixed cortical glial
cultures (primary culture) and isolated OPCs in the pres-
ence of PDGF AA (secondary culture) were characterized
immnunocytochemically by NG2 or PDGFRa expression.
For establishment of FABP7 stably over-expressing
cells, the coding region of mouse FABP7 gene was
ampliﬁed by PCR and sub-cloned into the pcDNA3
mammalian expression vector. The constructed expression
vector (pcDNA3 for mock, pcDNA3/FABP7) was trans-
fected into NG108 cells (rodent neuroblastoma/glioma
hybrid cells; a kind gift from Dr. K Fukunaga, Tohoku
University) using Lipofectamine 2000 (Invitrogen Co.,
Carlsbad, CA, USA) following the manufacturer’s
instructions, and the cells were selected for 2 weeks in
culture media supplemented with 0.5 mg/ml G418 (Sigma-
Aldrich, St. Louis, MO, USA). The resistant clones were
harvested, and the over-expression of the gene and protein
was conﬁrmed by RT-PCR and Western blot analysis,
respectively.
Immunohistochemistry
Animals were transcardially perfused with 4% parafor-
maldehyde (PFA) in 0.1 M sodium phosphate buffer (pH
7.4). Brains were removed, postﬁxed in 4% PFA (at least
for 4 h) and cryoprotected with graded sucrose (10, 20 and
30%; each for approximately 10 h) at 4C then stored at
-80C. Brain samples were cut into serial coronal 12- to
14-lm-thick sections with 50- to 60-lm intervals using a
cryostat (Leica CM1850; Leica, Nussloch, Germany) and
then mounted onto glass slides. Sections were rehydrated
in PBS containing 0.01% Tween 20 (TPBS) for 10 min,
permeabilized with 0.3% triton X-100 in PBS for 30 min,
washed three times in TPBS over 15 min and then blocked
in 5% skim milk in TPBS as blocking solution for 1 h at
room temperature. When using the antibody of mouse
origin, we used M.O.M Kit (Vector Laboratories, Burlin-
game, CA, USA) for masking the endogenous Fc recep-
tors. Sections were incubated in combinations of the
following primary antibodies for 16 h at 4C: rabbit anti-
FABP7 (0.5 lg/ml) (Abdelwahab et al. 2003), rabbit anti-
NG2, guinea pig anti-NG2 and rabbit anti-PDGFR-a
(1:1000, 1:50 and 1:1000, respectively, kindly provided by
W. Stallcup, Burnham Institute, http://www.burnham.org),
rat anti-GFAP (1:200, Invitrogen), mouse anti-NeuN
(1:100, Millipore, Billerica, MA, USA), mouse anti-MAP2
(1:500, Sigma-Aldrich), rat anti-CD11b (1:50, Chemicon,
Temecula, CA, USA), mouse anti-BrdU (1:100, BD
Pharmingens, San Diego, CA, USA) (see Supplementary
Table 1).
After primary antibody incubation, sections were
washed three times in TPBS for 30 min and incubated with
combinations of the following secondary antibodies for
30 min at room temperature: anti-rabbit IgG-Alexa488,
anti-rabbit IgG-Alexa 633, anti-mouse IgG-Alexa568, anti-
rat IgG-Alexa 568, and anti-guinea pig IgG-Alexa 555
(1:1000 for all; Invitrogen Co.). 40,6-Diamidino-2-pheny-
lindole (DAPI) (0.5 lg/ml, Invitrogen Co.) was added as a
nuclear marker. When required, Zenon rabbit IgG labeling
reagents (Molecular Probes, Invitrogen Co.) labeled with
Alexa Fluor 594 and Alexa Fluor 488 were used for
double-staining of rabbit primary antibodies. Slides were
cover-slipped using Fluoromount (DBS, CA, USA). For
negative controls of the antibodies used in this study, we
omitted the primary antibody reaction in the immunohis-
tochemical procedure and conﬁrmed the absence of the
reaction under such condition. Furthermore, for FABP7
antibody, the authenticity was conﬁrmed by the complete
absence of the reaction in FABP7-KO mouse tissues/cells.
BrdU uptake assay
For proliferation assay after stab injury, single intraperi-
toneal injection (100 mg/kg) of Brdu (Sigma-Aldrich) was
performed at 3 days after lesion (DPL3), and animals were
killed after 2 h (n = 4 for wild-type, n = 4 for FABP7-KO
mice) or 4 days after injection (DPL7: n = 4 for wild-type,
n = 4 for FABP7-KO mice) (White et al. 2010). For
cultured astrocytes, BrdU (10 lM) was added to culture
medium at 3 days after seeding when the astrocytes
reached a subconﬂuent state, and was incubated for 5 h.
BrdU
? cells were visualized immunocytochemically using
an anti-BrdU antibody as described previously with slight
modiﬁcations (White et al. 2010; Yang et al. 2009). Brieﬂy,
cells were incubated with 2 M HCl at room temperature for
30 min followed by washing twice with 0.1 M sodium
borate (pH 8.5) over 10 min. After blocking with 5% goat
serum at room temperature for 30 min, they were incubated
with mouse anti-BrdU antibody (1:100) at 4C overnight,
and incubated with anti-mouse IgG-Alexa568 (1:1000) at
room temperature for 1 h and then counterstained with
DAPI. After several washes with PBS, they were mounted
and cover slipped. Brain sections were pretreated by
microwave heating in citrate buffer (pH 6) at 96C for
10 min followed by incubation in 2 N HCl at 37C for
11 min and stained as described above.
Morphometric analysis
Sections were observed by a confocal laser scanning
microscope (LSM510 META; Carl Zeiss, Oberkochen,
Germany) and images were obtained in a 0.1 mm
2 area
(409 lens with 0.7 zoom, 317 9 317 lm), approximately
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1230.1 mm either lateral or medial to the edge of the lesion in
the gray matter of the cortex (mostly layers III and IV,
where astrocyte population includes only protoplasmic
astrocytes) (Nag 2011). Corresponding areas in the con-
tralateral cortex were also imaged. For BrdU assessment,
counts were performed in 0.4 mm
2 areas (209 lens with
0.7 zoom, 635 9 635 lm) from the edge of the lesion in
both the lateral and medial sides (see Supplementary
Fig. 1b).
Western blot analysis
Mice were killed 3 days after stab injury. The ipsilateral
cortex containing the stab injury and the corresponding
contralateral cortex were dissected (2 9 2 9 2m m
blocks). Whole tissue lysate was prepared in 29 SDS-
PAGE sample buffer containing protease inhibitors (Roche
Diagnostics, Mannheim, Germany). The lysates were
electrophoresed on a 15% SDS-polyacrylamide gel and
immunoblotted onto Immobilon-P
SQ PVDF membrane
(Millipore). After blocking with skim milk, membranes were
incubated with rabbit anti-FABP7 antibody (0.125 lg/ml)
(Abdelwahab et al. 2003) and mouse anti-b-actin antibody
(1:5000, Santa Cruz Biotech, Santa Cruz, CA, USA) over-
night at 4C followed by incubation with HRP-conjugated
goat anti-rabbit antibody (1:1000, Chemicon) and goat anti-
mouse antibody (1:1000, Chemicon). Detection of reactive
bands was performed using the ECL kit (Amersham Phar-
macia Biotech, Piscataway, NJ, USA).
3H-thymidine incorporation assay
Primary cultured astrocytes were incubated in 24-well
plates at the subconﬂuent status. The cells were then
incubated in fresh medium containing 10% fetal calf serum
and
3H-thymidine (1 lCi per well; Amersham, Piscataway,
NJ, USA) for 24 h at 37C. After incubation, the cells were
washed twice with 500 ll of ice-cold PBS (0.1 M; pH 7.4),
detached with trypsin–EDTA solution and collected on
GF/C ﬁlters (Whatman, Clifton, NJ, USA). The ﬁlters were
washed three times with 1 ml of 10% trichloroacetic acid
and rinsed twice with 1 ml of absolute ethanol. The
radioactivity contained on each ﬁlter was determined using
a scintillation counter (LSC-5100; Aloca, Tokyo, Japan).
Fatty acid incorporation assay
Primary cultured astrocytes were incubated in 12-well
plates. A 0.1 lCi/ml of
14C-linoleic acid or
14C-a-linolenic
acid (Amersham Pharmacia Biotech) was added to conﬂu-
ent cultured astrocytes. After incubation for 30–120 min,
the cells were washed thoroughly with cold PBS and lysed
with 0.1 M NaOH. Radioactivity was measured using a
b-scintillation counter. Radioactivity was normalized to the
DNA content of the sample.
Cell titer assay
The cell titer was quantiﬁed using the CellTiter 96
Aqueous One Solution Cell Proliferation Assay (Promega,
Madison, WI, USA) according to the manufacturer’s
manual. Brieﬂy, after seeding the cells onto 96-well plates
at the density of 1 9 10
4 cells/well, the coloring solution
was added to the culture media at each time point (0, 1, 2,
3, 4 and 5 days after seeding). Following incubation for
2 h, chromogenic development was measured at 490 nm
by spectrophotometer (Beckman Coulter, Fullerton, CA,
USA). The experiment was done in quadruplicate and the
mean value of optical density in each time point was
calculated.
Statistical analysis
All data are shown as mean ± SD. Statistical comparisons
of means were made by Student’s two-tailed unpaired t test
or, for multiple comparisons, one-way ANOVA followed
by the Tukey test. P values\0.05 were considered statis-
tically signiﬁcant.
Results
Localization of FABP7 in normal cortex
In the normal (intact) cortex, FABP7
? cells exhibiting
several cellular processes were evenly scattered throughout
the cortex. In these cells, FABP7 immunopositive staining
was observed in the nuclei and cytoplasm (Fig. 1). The
majority (62.7 ± 6.3%, n = 3) of the FABP7
? cells were
positive for NG2 proteoglycan, a marker for OPCs (termed
polydendrocytes) (Nishiyama et al. 2009) (Fig. 1a, f).
Conﬁrmation of FABP7
? cells as OPCs was further per-
formed by staining with PDGFRa, a speciﬁc marker of
OPCs (Zhu et al. 2010; Gao et al. 2010; Ozerdem et al.
2001; Nishiyama et al. 2009) (Fig. 1b). Furthermore,
97.1 ± 2.5% of NG2
? OPCs in the intact cortex were
FABP7
? (Fig. 1f). By contrast, 21.6 ± 3.7% of FABP7
?
cells in the intact cortex were GFAP
? astrocytes (Fig. 1c)
and 82.4 ± 10.6% of GFAP
? astrocytes were FABP7
?.I n
the upper layers near the dorsal surface of the cortex where
GFAP
? cells exhibit a higher population density, thicker
and less branched processes and more intensive expression
of GFAP (also known as interlaminar astrocytes, Nag
2011), GFAP
? astrocytes comprised near half of all
FABP7
? cells, with the remainder being NG2
? OPCs (data
not shown).
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123FABP7 was not colocalized with markers for neurons
including NeuN (Supplementary Fig. 2a) and MAP2
(Supplementary Fig. 2b), or with makers for microglia
including CD11b (Supplementary Fig. 2c). A 60% of cells
immunopositive for Olig2 (a common marker for all
oligodendrocyte lineage cells) did not express FABP7
(Supplementary Fig. 2d) suggesting down-regulation of
FABP7 during differentiation of OPCs to oligodendrocytes.
We also performed a systematic search in the transcriptome
databases of neural cells (Cahoy et al. 2008) and found that
the FABP7 gene was statistically enriched in puriﬁed
astrocytes and OPCs, conﬁrming our results. In the same
database, we found reciprocal enrichment of FABP7 in
OPCs and FABP5 in oligodendrocytes.
Fig. 1 Identiﬁcation of FABP7
expressing cells in the normal
adult cerebral cortex.
a–d Immunoﬂuorescence
micrographs showing
expression of FABP7 in OPCs
and astrocytes. a Expression of
FABP7 (green) in NG2
? OPCs
(red). b Expression of FABP7 in
OPCs conﬁrmed by
colocalization of FABP7
(green) and PDGFRa (red).
c Expression of FABP7 (green)
in GFAP
? protoplasmic
astrocyte. d Localization of
FABP7 (green) in NG2
? OPCs
(red) and GFAP
? astrocytes
(blue). Note that the majority of
FABP7
? cells are OPC. e Bar
graph showing the percentage
of NG2
? OPCs and GFAP
?
astrocytes among total FABP7
?
cells. f Bar graph showing the
percentage of FABP7
? cells in
NG2
? OPCs and GFAP
?
astrocytes. Data in e, f are
obtained from 0.1 mm
2 area.
Scale bars 20 lm
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123Taken together, these data suggest that mainly OPCs
and astrocytes comprise almost the entire population of
FABP7 expressing cells in the intact adult cortex. To our
knowledge, this is the ﬁrst time FABP7 has been shown on
OPCs. We also found strong expression of FABP7 on
OPCs in primary and secondary OPC cultures (see Sup-
plementary Fig. 3).
Localization of FABP7 in the stab-injured cortex
To evaluate changes in expression of FABP7 after cortical
stab injury, the stab-injured cortices at DPL3 and the con-
tralateral intact cortices were dissected for Western blot-
ting. FABP7 protein expression was signiﬁcantly increased
in the injured cortex compared with the contralateral side
(Fig. 2a). When assessed by immunohistochemistry, the
population density of FABP7
? cells signiﬁcantly increased
(approximately 35%) compared with the intact cortex
(Fig. 2b; 28.8 ± 1.9 cells at DPL3, 29.1 ± 1.3 cells at
DPL7 vs. 19.1 ± 1.4 cells in the intact cortex: p\0.05 and
p\0.01, respectively) in a 0.1 mm
2 area (0.1 mm lateral
or medial to the edge of injury). In contrast to the intact
cortex, the majority of FABP7
? cells (80.1 ± 0.2 and
82.8 ± 5.3% at DPL3 and DPL7, respectively) in the stab-
injured cortex were GFAP
? (Fig. 2c, g), while almost all
GFAP
? astrocytes (94.5 ± 0.8 and 97.0 ± 0.01% at DPL3
and DPL7, respectively) were positive for FABP7 (Fig. 2h).
The number of GFAP
?/FABP7
? cells signiﬁcantly increased
in number in the injured cortex (Fig. 2i; 23.3 ± 1.7 cells
and 24.4 ± 0.1 cells at DPL3 and DPL7, respectively, vs.
4.1 ± 0.5 cells in intact cortex in a 0.1 mm
2 area), indi-
cating a role for FABP7 in astrocyte proliferation.
A minor proportion of FABP7
? cells (35.2 ± 5.6 and
29.4 ± 2.5% at DPL3 and DPL7, respectively) in the stab-
injured cortex co-expressed NG2 (Fig. 2d). The expression
of FABP7
?/NG2
? cells in the injured cortex was similar to
that in the intact cortex and could be distinguished from
NG2
? pericytes in the stab-injured cortex as characterized
by their speciﬁc elongated morphology and their location
around the vessels and close to the injury core. Further-
more, these cells co-expressed PDGFRa (Fig. 2e), indica-
tive of OPCs rather than vascular pericytes.
While the total number of NG2
? cells signiﬁcantly
increased (approximately 30%) in the stab-injured cortex
compared with the intact cortex (21 ± 1.1 and 19.1 ± 2.1
cells/0.1 mm
2 at DPL3 and DPL7, respectively, vs. 14 ±
1.9 cells/0.1 mm
2 in the intact cortex; Supplementary
Fig. 4), the total number of NG2
?/FABP7
? cells did not
change (10.5 ± 2.8 and 9.2 ± 2.7 cells/0.1 mm
2 at DPL3
and DPL7, respectively, vs. 12.3 ± 2.2 cells/0.1 mm
2 in
the intact cortex; Fig. 2i). Furthermore, the total number of
PDGFRa
? cells did not signiﬁcantly differ between the
intact and injured cortex (16.4 ± 0.8 and 15.9 ± 4.4 cells/
0.1 mm
2 at DPL3 and DPL7, respectively, vs. 14 ± 1.1
cells/0.1 mm
2 in the intact cortex; Supplementary Fig. 4).
Similar to the intact cortex, in the stab-injured cortex,
FABP7 expression was not seen in neurons positive for
MAP2 or NeuN, or in microglia and/or monocyte-derived
cells positive for F4/80 or CD11b (data not shown).
Based on these results, localization of FABP7
? in
mainly NG2
? OPCs in the intact cortex is changed into
mainly GFAP
? astrocytes in the stab-injured cortex, due to
a profound increase in population density of GFAP
?
astrocytes. Taken together, these results suggest an asso-
ciation between FABP7 and proliferation of reactive
astrocytes after stab injury.
Role of FABP7 in proliferation of astrocytes
after stab injury
For further evaluation of the role of FABP7 in proliferation
of astrocytes, we examined whether FABP7-deﬁcient
astrocytes showed an altered proliferation in response to
stab injury. We quantiﬁed the number of BrdU
? astrocytes
and the total population of astrocytes in the cortices of
wild-type and FABP7-KO mice after stab injury. BrdU was
administered intraperitoneally to wild-type and FABP7-KO
mice at 3 days after cortical stab injury, and the number of
BrdU
? astrocytes was examined immunohistochemically
at 2 h (DPL3; n = 4 for each genotype) and 4 days (DPL7;
n = 4 for each genotype) after administration (Fig. 3a). In
the contralateral side of DPL3 and DPL7 brain cortices, a
few cells (1–2 cells per section) were labeled with BrdU,
and these were PDGFRa
?/GFAP
- cells, presumably pro-
liferating OPCs (Fig. 3b).
There were no differences in the total number of BrdU
?
cells (including blood derived cells and activated microg-
lia, reactive astrocytes, OPCs, pericytes and/or endothelial
cells) between the stab-injured cortex of wild-type and
FABP7-KO mice at either time points (Supplementary
Fig. 5f). The total number of BrdU
? cells increased
approximately twofold at DPL7, indicating that some of the
cells that were in S-phase at DPL3 proceeded to mitosis or
reentered the cell cycle until DPL7. Moreover, it is possible
that some cells may have proliferated several times
resulting in BrdU levels below the detectable limit.
At DPL3, there was no difference in the total number of
BrdU
?/GFAP
? cells between wild-type and FABP7-KO
mice (8.6 ± 2 cells/0.4 mm
2 in wild-type vs. 6.3 ± 3 cells/
0.4 mm
2 in FABP7-KO) (Fig. 3c, d, i), while at DPL7
there was a signiﬁcant difference between two groups
(29.3 ± 5.7 cells/0.4 mm
2 in wild-type vs. 18.3 ± 0.5
cells/0.4 mm
2 in FABP7-KO, p\0.05) (Fig. 3e, f, i).
Consistent with these data, the total number of GFAP
?
506 Histochem Cell Biol (2011) 136:501–513
123astrocytes was signiﬁcantly decreased in FABP7-KO
mice at DPL7 (125.7 ± 7.6 cells/0.4 mm
2 in wild-type
vs. 106.7 ± 5.5 cells/0.4 mm
2 in FABP7-KO, p\0.05)
(Fig. 3g, Supplementary Fig. 5a–d). The proportion of
BrdU
? astrocytes among the total astrocyte population also
signiﬁcantly decreased at DPL7 (25.67 ± 5.1% in wild-type
Fig. 2 FABP7 expression in stab-injured cortex. a Western blotting
showing increased expression of FABP7 in stab-injured cortex
compared with the intact cortex. b Bar graph showing increased
population density of FABP7
? cells in injured cortex compared to
intact cortex. c–f Immunoﬂuorescence micrographs showing expres-
sion of FABP7 in OPCs and astrocytes after cortical stab injury.
c Intensive expression of FABP7 (green) in hypertrophied GFAP
?
reactive astrocytes (red). d Expression of FABP7 (green) in NG2
?
OPCs (red). e Expression of FABP7 in OPCs after stab injury
conﬁrmed by colocalization of FABP7 (green) and PDGFRa (red).
f Localization of FABP7 (green) in GFAP
? astrocytes (blue) and
NG2
? OPCs (red) after stab injury. Note that the majority of FABP7
?
cells in stab-injured cortex are astrocytes. g Quantiﬁcation of
astrocytes and OPCs among FABP7
? cells in intact and injured
cortex. h Quantiﬁcation of FABP7
? cells among astrocytes and OPCs
in intact and injured cortex. i Population density of FABP7
?/GFAP
?
astrocytes and FABP7
?/NG2
? OPCs in intact and injured cortex.
Data in b, g, h, i are obtained from 0.1 mm
2 area. DPL days post
lesion. *p\0.05, **p\0.01, ***p\0.001. Scale bars 20 lm
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123vs. 17.55 ± 1.5% in FABP7-KO, p\0.05) (Fig. 3h). These
data show that astrocyte proliferation is decreased in
FABP7-KO after stab injury compared with wild-type,
suggesting a role of FABP7 in proliferation of astrocytes.
Role of FABP7 in astrocyte proliferation in vitro
FABP7 was abundantly expressed in primary cultured astro-
cytes at gene and protein levels (Supplementary Fig. 6a, b),
Fig. 3 Decreasedproliferationofreactiveastrocytesaftercorticalstab
injury in FABP7-KO mice. a BrdU administration paradigm: single
injection of BrdU was performed at 3 days after stab injury, and mice
were killed 2 h or 4 days later. b Immunoﬂuorescence micrograph
showing that few BrdU
? (red) cells were detected in the intact cortex
which were PDGFRa
? (green) OPCs. c–f Representative immunoﬂu-
orescence micrographs showing BrdU
?(green)cells andGFAP
?(red)
astrocytes in stab-injuredcortex in wild-type andFABP7-KO mice at3
and 7 days after stab injury. Note the lower number of BrdU
?/GFAP
?
astrocytes in FABP7-KO mice compared with wild-type mice,
especially in DPL7. g Bar graph showing the population density of
GFAP
? astrocytes in the stab-injured cortex of wild-type and FABP7-
KO mice. h Bar graph showing the proportion of BrdU
?/GFAP
?
astrocytes among total GFAP
? astrocytes in the stab-injured cortex of
wild-type and FABP7-KO mice. i Bar graph quantifying the popula-
tion density of BrdU
?/GFAP
? astrocytes in stab-injured cortex of
wild-type and FABP7-KO mice. Data in g, h, i are obtained from
0.4 mm
2 area. DPL days post lesion. *p\0.05. Scale bars 50 lm
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123and in immunocytochemistry FABP7 was predominantly
localized to the cell nuclei of cultured astrocytes (Supple-
mentary Fig. 6c). To study the role of FABP7 in astrocyte
proliferation, we examined BrdU and
3H-thymidine
incorporation in subconﬂuent primary cultured astrocytes
from wild-type and FABP7-KO mice. The BrdU labeling
index (proportion of BrdU
? astrocytes among all astro-
cytes) was signiﬁcantly decreased (by approximately 30%,
p\0.05) in FABP7-KO astrocytes compared with wild-
type (Fig. 4a, Supplementary Fig. 7c, d). Similarly, the
uptake of
3H-thymidine in FABP7-KO astrocytes was
signiﬁcantly decreased (by approximately 20%, p\0.05)
compared with wild-type (Fig. 4b). Delayed conﬂuency
was consistently observed in FABP7-KO astrocytes com-
pared with wild-type (Supplementary Fig. 7a, b). These
data further conﬁrm the role of FABP7 in astrocyte pro-
liferation. Next, we transfected FABP7 into NG108 cells,
neuroblastoma and glioma hybrid cells, which show no
endogenous FABP7 expression (Supplementary Fig. 7e).
There was a signiﬁcant increase in the proliferation of
FABP7 transfected cells compared with mock-transfected
cells (Supplementary Fig. 7f).
We also evaluated the uptake of a-linolenic acid (
18C3,
n-3) and linoleic acid (
18C2, n-6) in FABP7-KO astrocytes.
There was a decrease in incorporation of a-linolenic acid
(
18C3, n-3) in FABP7-KO astrocytes (p\0.05; Fig. 4c),
while no difference was observed in that of linoleic acid
(
18C2, n-6) (Fig. 4d). Taken together, these data suggest
that FABP7 is involved in the proliferation of astrocytes by
controlling fatty acid homeostasis (metabolism/signal
transduction).
Discussion
FABP7 is abundantly expressed in neural stem cells and
radial glia of the developing brain and has been associated
with a number of brain diseases including psychotic dis-
orders (Owada et al. 1996; Watanabe et al. 2007; Maekawa
et al. 2011) or brain tumors (Godbout et al. 1998; Tso et al.
2006; Liang et al. 2005; Kaloshi et al. 2007). However, the
underlying mechanisms of the actions of FABP7 are poorly
understood, particularly in the adult brain under normal and
pathologic conditions. Herein, we identiﬁed FABP7
expressing cells in the adult mouse cortex as both OPCs
and astrocytes and found that FABP7 expression was
markedly increased in the astrocytes after cortical injury.
Furthermore, we examined the phenotype of FABP7-KO
mice after cortical stab injury to study the role of FABP7 in
gliosis and found that FABP7 played a critical role in
regulating astrocyte proliferation in vivo.
Decreased proliferation of reactive astrocytes in
FABP7-KO mice is one of the main ﬁndings in this study.
Fig. 4 Decreased proliferation and fatty acid incorporation in
primary cultured FABP7-KO astrocytes. a Bar graph showing
decreased BrdU
? cells at 3 days after passage in FABP7-KO cultured
astrocytes compared with wild-type. b Bar graph showing decreased
H-thymidine uptake in FABP7-KO cultured astrocytes compared with
wild-type astrocytes. Bar graphs showing incorporation of n-3 (c) and
n-6 (d) fatty acids in wild-type and FABP7-KO cultured astrocytes.
*p\0.05
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123We previously reported that FABP7 was substantially
expressed by GFAP
? astrocytes in the cortex of early
postnatal developing brain (Owada et al. 1996), and that
the number of GFAP
? cells (neural stem cells and early
progenitors) and total BrdU uptake were decreased in the
hippocampal dentate gyrus of the FABP7-KO mice at
postnatal 4 weeks (Watanabe et al. 2007). However, no
signiﬁcant difference in the astrocyte population was
detected in the normal adult cortex between wild-type and
FABP7-KO mice in this study. One possible explanation is
that the cellular demand of fatty acids was developmentally
compensated in the FABP7-KO brain by the redundant
molecule such as FABP5, another FABP expressed weakly
in the astrocytes, while the dramatic increase in the fatty
acid requirement for astrocyte proliferation during reactive
gliosis, possibly for rapid remodeling of membrane lipid,
was not fully covered. Another possibility is that the
mechanism by which FABP7 controls astrocyte biology
under pathological condition (gliosis process) is partly
distinct from that in the normal brain development. How-
ever, this study demonstrated that the primary cultured
FABP7-KO astrocytes showed the decrease in proliferation
and the late conﬂuency, suggesting that FABP7-KO mice
may reach to the normal population of astrocytes in the in
vivo cortex later than wild-type mice. This hypothesis
should be further examined through careful quantiﬁcation
of cortical astrocytes in different developmental stages in
FABP7-KO mice.
Primary cultured astrocytes from FABP7-KO mice
showed a decrease in proliferation and a decrease in the
cellular uptake of a-linolenic acid (
18C3, n-3), while there
was no decrease in that of linoleic acid (
18C2, n-6). These
data are consistent with the previous ﬁnding that FABP7
binds to n-3 PUFAs with high afﬁnity (Balendiran et al.
2000), suggesting that FABP7 is involved in proliferation of
astrocytes by controlling fatty acid homeostasis (metabo-
lism/signal transduction). Although the role of n-3 PUFA in
the astrocyte proliferation remains unknown, Tian et al.
(2011) recently reported that dietary supplementation of the
female mice during pregnancy and lactation period with n-3
PUFA results in increased numbers of GFAP
? astrocytes
and increased expression of PPARc in the developing brain
(Tian et al. 2011). Champeil-Potokar et al. (2004) reported
an increased proliferation of primary cultured astrocytes
supplemented with DHA by assessing DNA concentration.
They also found an increased n-3 PUFAs and DHA com-
position of membrane phospholipids in astrocytes after
supplementation with DHA (Champeil-Potokar et al. 2004).
Although the molecular mechanism by which FABP7 reg-
ulates astrocyte proliferation remains to be studied, it has
been recently shown that transfection of FABP7 in FABP7
-
U87 cells (malignant glioma cell line) causes increased
expression of growth factors such as FGF2 (Kipp et al.
2011), which is known to promote astrocyte proliferation
(Stachowiaketal.1997;Joyetal.1997;Gomez-Pinillaetal.
1995). The same group also reported the morphological
difference between FABP7
? and FABP7
- U87 cells (Mita
et al. 2007), in contrast to our not noticing any difference in
the morphology of cortical astrocytes in the adult brain
(Owada et al. 2006) and in the primary cultured astrocytes
between wild-type and FABP7-KO mice. Although the
immortalizedglioma cells and astrocytes are distinct intheir
biological characteristics, it is crucial and interesting to
measure the expression levels of growth factors in the
FABP7-KO astrocytes and further to examine whether
decreased proliferation of reactive astrocytes in FABP7-KO
mice has any impact on neuronal outcome including neu-
ronal survival and/or regeneration after the brain damage.
We found that the major population of FABP7
? cells in
the adult cortex was OPCs. OPCs are distributed through-
out the gray and white matter and are the most prevalent
cycling progenitors in the adult CNS (Dawson et al. 2003;
Geha et al. 2010; Simon et al. 2011). OPCs are functionally
and antigenically distinct from neurons, mature oligoden-
drocytes, astrocytes and microglia, and as such, are
regarded as the fourth major glial population (Nishiyama
et al. 2009). Several studies have reported that OPCs
generate oligodendrocytes in the developing and mature
CNS (Simon et al. 2011; Nishiyama et al. 2009) and that
OPCs respond by proliferating, migrating, and differenti-
ating into myelinating oligodendrocytes following demye-
lination (Levine et al. 2001; Levine and Reynolds 1999;
Islam et al. 2009; Franklin 2002; Franklin et al. 2002;
Watanabe et al. 2002). We also found that only a sub-
population of oligodendrocyte lineage cells expressed
FABP7, suggesting that FABP7 is downregulated during
differentiation of OPCs to oligodendrocytes. This ﬁnding
was conﬁrmed by our analysis of the transcriptome data-
base of isolated neural cells (Cahoy et al. 2008), suggesting
a role of FABP7 in OPC differentiation. Failure of OPCs to
differentiate into myelinating oligodendrocytes results in
failure of spontaneous remyelination, which is important in
the pathophysiology of demyelinating disorders such as
multiple sclerosis (Chang et al. 2002; Kuhlmann et al.
2008). Of interest, activation of RXRc was reported to
stimulate differentiation of OPCs to enhance remyelination
(Huang et al. 2011), while FABPs can regulate gene
expression by activation of nuclear receptors such as
PPARs and RXRs (Kitajka et al. 2004; Schroeder et al.
2008). There are also several reports addressing the effects
of n-3 PUFA on stimulation of the myelinogenesis process
(DeWille and Farmer 1992; Martinez and Vazquez 1998;
van Meeteren et al. 2006; Salvati et al. 2008). Our tran-
scriptome database search of spontaneous remyelination
(Huang et al. 2011) showed that FABP7 is upregulated
during remyelination, suggesting a possible role of FABP7
510 Histochem Cell Biol (2011) 136:501–513
123in the process of OPC differentiation and remyelination.
Although the role of FABP7 in OPC biology remains to be
elucidated, the conﬁrmation of strong expression of FABP7
in the primary and secondary cultured OPCs in our study
suggests an important role and may enable us to do further
detailed studies.
In contrast to several previous studies that reported
increased number of OPCs after stab injury (Rhodes et al.
2006; Simon et al. 2011; Hampton et al. 2004; Buffo et al.
2005; Levine 1994; McTigue et al. 2001; Alonso 2005), we
did not detect any signiﬁcant changes in OPC numbers
between normal and stab-injured cortex. This discrepancy
can be partly explained by different sizes of the observation
area and its distance from the edge of the injury as well as
the different markers used for OPC labeling. Previous
reports used mainly NG2 for identiﬁcation of OPCs, which
is also expressed by pericytes and activated microglia, in
the injured cortex. In this study, quantiﬁcation of OPC in
the stab-injured cortex was conﬁrmed by using PDGFRa
positivities as the most speciﬁc marker for OPCs combined
with co-expression of NG2 and FABP7. Interestingly,
Hampton et al. (2004) showed that the total number of
PDGFRa
? cells remained constant after injury, while the
number of NG2
? cells increased (Hampton et al. 2004).
These results were, however, explained by proposing a
NG2
?/PDGFRa
- subpopulation of OPCs, which is not
consistent with the current understanding of the antigenic
characteristics of OPCs.
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